Logo image of DSS

DSS INC (DSS) Stock Fundamental Analysis

NYSEARCA:DSS - US26253C2017 - Common Stock

1.23 USD
-0.06 (-4.65%)
Last: 8/29/2025, 8:17:28 PM
1.1801 USD
-0.05 (-4.06%)
After Hours: 8/29/2025, 8:17:28 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to DSS. DSS was compared to 84 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of DSS have multiple concerns. DSS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year DSS has reported negative net income.
In the past year DSS has reported a negative cash flow from operations.
In the past 5 years DSS reported 4 times negative net income.
In the past 5 years DSS always reported negative operating cash flow.
DSS Yearly Net Income VS EBIT VS OCF VS FCFDSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

DSS's Return On Assets of -51.50% is on the low side compared to the rest of the industry. DSS is outperformed by 85.71% of its industry peers.
Looking at the Return On Equity, with a value of -266.50%, DSS is doing worse than 85.71% of the companies in the same industry.
Industry RankSector Rank
ROA -51.5%
ROE -266.5%
ROIC N/A
ROA(3y)-40.24%
ROA(5y)-26.07%
ROE(3y)-135.15%
ROE(5y)-84.67%
ROIC(3y)N/A
ROIC(5y)N/A
DSS Yearly ROA, ROE, ROICDSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DSS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DSS Yearly Profit, Operating, Gross MarginsDSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1

2. Health

2.1 Basic Checks

DSS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DSS has more shares outstanding
Compared to 5 years ago, DSS has more shares outstanding
Compared to 1 year ago, DSS has an improved debt to assets ratio.
DSS Yearly Shares OutstandingDSS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
DSS Yearly Total Debt VS Total AssetsDSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -4.95, we must say that DSS is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -4.95, DSS is doing worse than 84.52% of the companies in the same industry.
DSS has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.13, DSS is in the better half of the industry, outperforming 72.62% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z -4.95
ROIC/WACCN/A
WACC5.76%
DSS Yearly LT Debt VS Equity VS FCFDSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.98 indicates that DSS may have some problems paying its short term obligations.
DSS has a Current ratio of 0.98. This is in the lower half of the industry: DSS underperforms 76.19% of its industry peers.
A Quick Ratio of 0.93 indicates that DSS may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.93, DSS is doing worse than 71.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.93
DSS Yearly Current Assets VS Current LiabilitesDSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

1

3. Growth

3.1 Past

DSS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.65%, which is quite impressive.
Looking at the last year, DSS shows a decrease in Revenue. The Revenue has decreased by -9.50% in the last year.
The Revenue has been growing slightly by 4.20% on average over the past years.
EPS 1Y (TTM)39.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.17%
Revenue 1Y (TTM)-9.5%
Revenue growth 3Y-1.98%
Revenue growth 5Y4.2%
Sales Q2Q%27.98%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DSS Yearly Revenue VS EstimatesDSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
DSS Yearly EPS VS EstimatesDSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400 -500

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DSS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DSS Price Earnings VS Forward Price EarningsDSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DSS Per share dataDSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

DSS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DSS INC

NYSEARCA:DSS (8/29/2025, 8:17:28 PM)

After market: 1.1801 -0.05 (-4.06%)

1.23

-0.06 (-4.65%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)08-11 2025-08-11
Earnings (Next)11-11 2025-11-11
Inst Owners1.81%
Inst Owner Change-0.68%
Ins Owners13.06%
Ins Owner Change0%
Market Cap11.18M
Analysts80
Price TargetN/A
Short Float %1.19%
Short Ratio0.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.55
P/FCF N/A
P/OCF N/A
P/B 0.63
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-6.6
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.98
FCFYN/A
OCF(TTM)-0.94
OCFYN/A
SpS2.22
BVpS1.97
TBVpS-0.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -51.5%
ROE -266.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-40.24%
ROA(5y)-26.07%
ROE(3y)-135.15%
ROE(5y)-84.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 14.77%
Cap/Sales 1.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.93
Altman-Z -4.95
F-Score4
WACC5.76%
ROIC/WACCN/A
Cap/Depr(3y)16.53%
Cap/Depr(5y)165.83%
Cap/Sales(3y)3.35%
Cap/Sales(5y)34.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.17%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.5%
Revenue growth 3Y-1.98%
Revenue growth 5Y4.2%
Sales Q2Q%27.98%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y20.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y76.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.57%
OCF growth 3YN/A
OCF growth 5YN/A